US Patent Issued to Bivision Pharmaceuticals on Sept. 30 for "Peptide-urea derivative, pharmaceutical composition containing same and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,211, issued on Sept. 30, was assigned to Bivision Pharmaceuticals Inc. (Nanjing, China).

"Peptide-urea derivative, pharmaceutical composition containing same and application thereof" was invented by Haihua Yu (Jiangsu, China), Eric Yanjun Wang (Jiangsu, China) and Kevin Yu Wang (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A peptide-urea derivative, a pharmaceutical composition containing same and an application thereof are provided, the derivative being as shown in formula I. The derivative can be used for preoperative imaging diagnosis and grading of PSMA-positive prostate cancer, and can also be used for the treatment of various...